Featured Research

from universities, journals, and other organizations

Gene Variant Increases Heart Disease Risk, Even When Cholesterol Is Normal

Date:
November 9, 1999
Source:
American Heart Association
Summary:
A gene already implicated in high cholesterol may pose yet another risk for heart disease, according to a study presented at the American Heart Association's Scientific Sessions.

ATLANTA, Nov. 7 -- A gene already implicated in high cholesterol may pose yet another risk for heart disease, according to a study presented today at the American Heart Association's Scientific Sessions.

Apolipoprotein E is a key protein involved in the transport and disposal of cholesterol in the body. Sitting on the surface of circulating blood-fat particles, apo E normally binds to liver cells, to help rid the body of cholesterol. There are three variants of apo E.

Lead investigator of the study, Angelo Scuteri, M.D., Ph.D., of the National Institute of Aging in Baltimore, Md., says research suggests that one of the variants, apoE-4, raises levels of total cholesterol and "bad" low-density lipoprotein, or LDL. Too much cholesterol in the blood can block blood vessels, setting the stage for a heart attack or stroke.

To determine if the apoE-4 variant was associated with heart disease, Scuteri and his colleagues studied 731 healthy men and women in the Baltimore Longitudinal Study of Aging, a study that began in 1958 and involved individuals ranging in age from 21 to 96. The study participants underwent physical, physiological and psychological exams every two years for 17 years. The study included men and women age 50 or older who had no apparent signs of heart disease. More than half (57 percent) of the participants were men.

Gene testing revealed that 200 of the 731 individuals had the apoE-4 gene, and they also were more likely to have a "coronary event" later in life than those without the variant--roughly 20 percent versus 13 percent in the non-mutation group. Coronary events were defined as angina (chest pain), heart attacks or dying from heart attack or another form of coronary heart disease.

A surprising finding was that individuals with apoE-4 still had an increased risk of heart disease, even if their cholesterol levels and blood pressure were normal.

Overall, there were 104 coronary events among the study group. Because most of those events were angina (severe chest pain due to blockages), Scuteri says a separate analysis was done for heart attacks and deaths. The results were similar to the original finding that the apoE-4 gene variant significantly increases an individual's risk of heart disease.

"Prior studies suggested that the major effect from apoE-4 was an increase in cholesterol levels. We showed that the association with heart attack was found even when an individual's cholesterol level was normal. So there may be another, yet to be determined, explanation for the adverse effects of apo-E4," says Scuteri.

"It is interesting that our study shows an association between apo-E4 and the incidence of coronary events that is independent of cholesterol levels. This means that the apo-E4 gene provides information about overall cardiovascular risk that is separate from cholesterol," he says.

One aim of the study of genetic markers in cardiovascular disease is to possibly tailor the treatment according to gene type. There is no data to support the hypotheses that the apo-E4 gene may predict how an individual will respond to cholesterol-lowering medication. However, the apo-E4 gene has been reported to predict the cholesterol response to estrogen replacement therapy in post-menopausal women.

Although researchers stress that their findings are preliminary, they say the apoE-4 gene may emerge as an important gene target for treating heart attacks. "Our goal is to provide doctors with blood tests or markers that will enable them to predict and treat heart disease earlier. Since we cannot change the genes, individuals with apoE-4 may require earlier treatment," he says. "But we cannot consider our data conclusive at this point. It needs to be confirmed in other population groups."

Co-authors are Angelo J.G. Bos, M.D., Ph.D.; Alan B. Zonderman, Ph.D.; Larry J. Brandt, Ph.D.; Edward Lakatta, M.D. and Jerome L. Fleg, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Gene Variant Increases Heart Disease Risk, Even When Cholesterol Is Normal." ScienceDaily. ScienceDaily, 9 November 1999. <www.sciencedaily.com/releases/1999/11/991109072410.htm>.
American Heart Association. (1999, November 9). Gene Variant Increases Heart Disease Risk, Even When Cholesterol Is Normal. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/1999/11/991109072410.htm
American Heart Association. "Gene Variant Increases Heart Disease Risk, Even When Cholesterol Is Normal." ScienceDaily. www.sciencedaily.com/releases/1999/11/991109072410.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins